Ethambutol and Isoniazid: The Eye Toxicity to Know About During TB Treatment
TB Medicines and Your Eyes at a Glance
If you take ethambutol and your sight changes, treat it as urgent. Call the doctor who prescribes your TB medicine the same day. Do not wait for your next visit. Call right away for any of these:
- Blurred or decreased vision in one eye or both
- Colors looking dull, washed out, or wrong
- A dim or blank patch in the middle of your sight
- Trouble reading print you could read last month
- Any new loss of vision
Here is the calming part. The US label for ethambutol says this effect is generally reversible when the drug is stopped promptly, though irreversible blindness has been reported1. Speed is what protects your sight. Do not stop your TB medicine on your own. Your TB doctor decides what to change, and calling the same day gives them that chance.
Ethambutol is the one to watch. Its label carries a warning that the drug may lower visual acuity through inflammation of the optic nerve, the cable that carries pictures from your eye to your brain1. Isoniazid belongs in this conversation too, but in a smaller role. Isoniazid can independently cause a similar optic nerve problem, and people on both drugs together have been described as facing added risk2. Most of what follows is therefore about ethambutol, with isoniazid handled where it genuinely matters.
| What differs | Ethambutol | Isoniazid |
|---|---|---|
| Eye risk | The well-documented one, carried in the drug's own label | Reported far less often, mainly in individual case reports |
| Main nerve effect | Optic nerve, affecting central vision and color | Nerves in the hands and feet more than the eye |
| Routine monitoring | Baseline eye testing, then monthly checks | Vitamin B6 given alongside it for people at risk of nerve damage |
Being told a medicine can harm your eyes is unsettling, so hold two facts together. Optic nerve damage occurs in roughly 1 to 2 of every 100 people treated with ethambutol, with the figure tracking the daily dose2. That means most people finish TB treatment with their vision intact. The people who run into trouble and act quickly have the best chance of getting sight back. Knowing the warning signs is what converts a rare risk into a manageable one.
What Ethambutol Optic Neuropathy Is
Ethambutol works by weakening the wall that tuberculosis bacteria build around themselves. The mechanism of the eye injury is not settled, but the drug and one of its breakdown products bind metals, which may interfere with the energy-producing machinery inside optic nerve fibers3. Whatever the mechanism turns out to be, the pattern it produces is consistent: the loss shows up in central vision and color rather than at the edges of your view3.
The risk is not fixed. It rises steeply with the daily dose relative to your body weight. At the World Health Organization's recommended daily dose the figure averages about 1 of every 100 people, rising to about 5 or 6 of every 100 at higher daily doses and to about 18 of every 100 at the highest doses studied3. Your prescriber calculates your dose from your weight and your kidney function, which is one reason those numbers get rechecked during treatment.
There is no single window in which this happens, which is why monitoring runs the whole course. Onset averages about 3 to 5 months after starting the drug but can occur at any point in the treatment course3. Symptoms have been described as developing anywhere from 1 month to 36 months after the drug is started2. Feeling fine at month two says nothing about month six, so the checks continue even when everything has gone smoothly.
What Raises and Lowers Your Risk
Several ordinary health problems shift the odds. Risk is higher with kidney dysfunction, smoking, poorly controlled diabetes, high blood pressure, age over 65, malnutrition, and changes in body weight or kidney function during treatment3. A nationwide study of 204,598 people starting ethambutol also linked higher risk with female sex, malnutrition, diabetes, high blood pressure, high cholesterol, kidney disease, liver disease, and a higher total amount of drug taken over the course4. None of these rules you out of treatment; they change how closely you are watched.
Your kidneys clear ethambutol from your blood. When they work less well, the drug lingers and its level climbs. The label states that patients with decreased kidney function need the dose reduced, guided by blood levels of the drug1. The expert consensus lists kidney disease among the conditions that warrant an eye examination at the start of treatment rather than later5. If your kidney numbers change mid-treatment, tell both your TB team and your eye doctor, because that is a reason to look sooner.
This is the part worth reading slowly, because good sources point in opposite directions. One clinical review lists concurrent isoniazid among the factors that raise the risk of ethambutol optic neuropathy3. The 204,598-person national study found the opposite, with isoniazid alongside ethambutol linked to a lower rather than higher risk, which the authors attributed to shorter ethambutol courses and possibly to the vitamin B6 routinely given with isoniazid4. The honest summary is that isoniazid's separate contribution remains unsettled, and it does not change what you should do.
Age sits on both ends of this question. The label does not recommend ethambutol for children under 13 years of age, because safe conditions for its use in that group have not been established1. At the other end, age over 65 is a recognized risk factor, and recovery after the drug is stopped is markedly better under age 60 than over it3. For an older adult on ethambutol, that is an argument for reporting a change early rather than an argument against the medicine.
The Symptoms to Watch For
Color changes belong on the same list as blurred vision, and they are easy to overlook. Difficulty telling colors apart is a characteristic feature of ethambutol optic neuropathy3, and loss of red-green color discrimination is the pattern most commonly described2. This is why the consensus panel asks patients to report altered color perception or reduced brightness, alongside decreased vision, reading difficulty, and frequent changes of eyeglasses5. Checking one eye at a time against something reliably colored helps you notice a shift.
The pattern is distinctive, and knowing it helps you describe it accurately on the phone. The typical picture is bilateral, painless, progressive loss of central vision, with a dim or blank patch in the middle of sight on formal testing3. Central visual acuity loss affecting both eyes appears in more than 60 of every 100 affected patients2. Nothing hurts, which is exactly the trap. Painless change is still urgent change here.
Not every eye complaint during TB treatment is the drug. Gritty, watery, or itchy eyes, sensitivity to bright light without vision loss, and a gradual need for stronger reading glasses over years are ordinary and common. So is blurring that clears when you blink. What sets drug toxicity apart is painless, persistent loss of clarity or color in the middle of your sight, usually in both eyes. When in doubt, describe what you see and let your team sort it out; that call costs you very little.
How Doctors Check and Confirm It
Good monitoring starts with a measurement taken before the drug does anything. The joint American Thoracic Society, CDC, and Infectious Diseases Society of America guideline advises baseline visual acuity testing with a Snellen chart and baseline color discrimination testing before ethambutol is started6. The label likewise directs that visual acuity be tested before beginning therapy, with the examination including a look at the optic nerve, a check of side vision, and color discrimination testing1. Without that first reading, a later result has nothing to be compared against.
Monitoring is deliberately repetitive, because that is what catches a slow change. The joint guideline calls for monthly questions about visual disturbance and monthly color discrimination testing during treatment6. EyeWiki describes monthly assessment of central vision, color vision, and an Amsler grid, with monthly checks particularly important for people on higher doses, longer courses, or with reduced kidney function2. Ask your team what your schedule is and who is doing which test, so nothing falls between two clinics.
An urgent visit is more thorough than a monthly check. A full assessment includes visual acuity, visual field testing, color vision, contrast sensitivity, a dilated look at the optic nerve, and scans of the nerve fiber layer where available3. Early on the optic nerve can look entirely normal on examination even when vision has already changed3, so a reassuring photograph is not the end of the story. The measurements matter more than the appearance, which is why the same tests get repeated.
There is no blood test or scan that confirms this diagnosis outright. The case is built from the pattern: which drug you take, how long you have taken it, what your vision measured before, and what it measures now. That is the practical reason baseline testing matters so much, and the reason you should mention every medicine you take, including anything started recently. A missing baseline does not make diagnosis impossible, but it makes it slower at the exact moment speed counts.
What Treatment Looks Like
The treatment is subtraction, not addition. The expert panel states that ethambutol should be discontinued at the first sign of eye toxicity in consultation with the treating physician, and that stopping the drug is essential because there is no other definitive treatment5. A recent review agrees that no proven treatment exists beyond early detection, prompt discontinuation, and switching to alternative TB drugs3. Vitamin combinations are sometimes added, but the decisive step is removing the drug.
This deserves its own heading because the instinct to act alone is strong and the consequences are real. The joint treatment guideline stresses that continuous treatment matters most in the early intensive phase, when the bacterial population is highest and the chance of drug resistance developing is greatest, and that a lapse of 14 days or more in that phase means starting the whole regimen again6. The expert panel frames discontinuation as a step taken in consultation with the treating physician5, and the label's instruction to patients is to report any change in vision promptly to their doctor1. Your job is the phone call the same day. The prescription change is theirs.
TB treatment is built from several drugs, so removing one does not leave you untreated. Management involves stopping ethambutol and switching to alternative agents, which may include fluoroquinolone antibiotics or newer TB drugs depending on the situation3. Which substitute suits you depends on the type of infection, resistance testing, your other medicines, and your kidney and liver function. That is a decision for the TB service, and it is usually made quickly once a vision change is confirmed.
Recovery, Risks, and a Realistic Outlook
The outlook is genuinely mixed, and it rewards early action. Between 30 and 64 of every 100 patients show improvement over several months when the drug is stopped before the optic nerve has wasted, averaging about two lines on a standard eye chart, though full recovery is uncommon2. Complete recovery has been documented in several cases over 1 to 6 months when ethambutol was stopped early5. Timing is the part of this you can influence.
This surprises people and can be frightening if nobody warns you. Visual function may continue to deteriorate for a few weeks even after the drug is stopped5. That does not mean stopping was pointless or that the diagnosis was wrong. The nerve takes time to settle after the exposure ends, and improvement, where it comes, tends to arrive over months rather than days. Knowing the shape of the curve makes the first few weeks easier to sit with.
Two factors move the outlook more than anything else. Recovery approaches 80 of every 100 patients under age 60, compared with about 20 of every 100 over age 60, and a pale optic nerve at the first visit signals a poorer outlook3. Irreversible loss can occur despite close monitoring and prompt discontinuation3. That is the honest floor of this page. It is also the strongest argument for making the call on day one rather than week three.
When to Call, and Who to Call
Anything below deserves a same-day call to the doctor who prescribes your TB medicine, even if it seems minor:
- Blurred vision, or letters on a page becoming harder to make out
- Colors looking faded, or red and green becoming harder to tell apart
- A dim or missing patch in the center of your sight in either eye
- Needing much more light than usual to read
- Any change in sight after a change in your dose or your kidney results
A separate group of problems is not about your TB medicine and needs same-day care of its own: severe eye pain, a red and painful eye, a dark curtain or shadow crossing your sight, or a sudden shower of new floaters with flashing lights. Those point to other eye conditions that are treated urgently, and treated quickly most do well.
Not everything is an emergency. Questions about when your next color vision test is due, whether your dose still matches your weight, and how long you will stay on ethambutol are all good agenda items for your next appointment. So are dry, gritty eyes and the ordinary need for a new glasses prescription. The line worth remembering is simple: anything that touches the clarity or color of your central vision gets a call, and everything else can queue.
Two teams share this. The TB service owns the diagnosis, the drug list, and any decision to change it. The eye clinic owns the measurements and their interpretation, and complex optic nerve problems are often referred to a neuro-ophthalmologist. Make sure each side knows the other exists: ask that your eye results go to your TB team, and tell your eye doctor exactly which TB drugs you take and for how long you have taken them.
Common Questions About TB Medicines and Your Eyes
No. Optic nerve damage is reported in roughly 1 to 2 of every 100 people treated with ethambutol, so most people complete treatment with their sight unaffected. The risk rises with a higher daily dose relative to body weight, longer treatment, and reduced kidney function. The point of baseline testing and monthly checks is to catch a change in the small group who do run into trouble, at a stage where stopping the drug still has something to protect.
Color changes are one of the characteristic signs, so give them the same weight as blurring. Reds and greens can become harder to tell apart, and colors can look washed out or less bright. Reading may become effortful, and a dim patch can appear in the middle of your sight. Check one eye at a time by covering the other, using something with reliable color, and compare the two. Any difference that persists is worth a same-day call.
No. Call the doctor who prescribes your TB medicine the same day and let them decide. Stopping TB treatment without guidance can allow the infection to come back and can encourage drug resistance, which makes it harder to treat. Guidance frames discontinuation as a decision made with your treating physician. Your part is to report the change fast and clearly. Their part is the prescription.
The evidence disagrees, and it is fair to say so. One clinical review lists concurrent isoniazid among factors that raise risk, while a national study of more than 200,000 ethambutol users found isoniazid linked to lower risk, possibly because it shortens ethambutol courses and because vitamin B6 is routinely given alongside it. Either way, isoniazid does not change what you do: report vision changes the same day and keep your monitoring appointments.
Vitamin B6, also called pyridoxine, is given together with isoniazid to people at risk of nerve damage, including those who are pregnant or breastfeeding, or who have HIV, diabetes, alcohol dependence, malnutrition, chronic kidney failure, or advanced age. It is prescribed to protect nerves, not to treat an eye problem you already have. Take it as your team directs, and do not treat it as a substitute for the vision checks.
No, because a normal result covers only the day it was taken. Symptoms have been described appearing anywhere from one month to three years after starting the drug, and the average onset is several months in. A clear check at month two says nothing about month six. The tests are quick, and their whole value comes from being repeated so a change can be seen against your own earlier result.
More Questions About Testing, Recovery, and Next Steps
The joint TB treatment guideline calls for visual acuity on a standard chart and color discrimination testing before ethambutol is started. Expert consensus adds contrast sensitivity and visual field testing, and recommends that higher-risk patients, including older adults and people with kidney disease, diabetes, malnutrition, or heavy tobacco or alcohol use, see an ophthalmologist at the start rather than later. Ask for a copy of your baseline results to keep.
Months rather than days, and improvement is often partial. Where the drug was stopped before the optic nerve wasted, between 30 and 64 of every 100 patients improve over several months, averaging about two lines on an eye chart. Complete recovery has been documented in some cases over one to six months with early discontinuation, but it is uncommon. Vision can also dip for a few weeks after stopping before any improvement begins.
That is a reasonable request to make. Monthly checking is the recommended baseline, and more frequent assessment is commonly used for people on higher doses, longer courses, or with reduced kidney function. Your own reporting between visits matters just as much as the formal schedule, since a change you notice does not have to wait for the next scheduled test. Ask your team what would trigger an earlier appointment.
Yes. Ethambutol is also used for other mycobacterial infections, often for longer courses, and the eye risk travels with the drug rather than with the diagnosis. Longer total exposure and higher cumulative dose are both associated with greater risk. If you are on an extended course, confirm that your baseline testing was done and that someone owns your monitoring schedule, since long treatments are exactly where checks tend to lapse.
A written list gets further than remembering one question at the door. These are worth asking:
- Was a baseline visual acuity and color vision test done before I started, and what did it show?
- How was my ethambutol dose calculated, and does it account for my kidney function?
- Who checks my vision each month, and how do I book that?
- Which number do I call if my vision changes outside office hours?
- Do any of my other conditions or medicines raise my risk?
- If ethambutol has to stop, what would replace it in my regimen?
- DailyMed, US National Library of Medicine (Epic Pharma label, revised 2023) (2023). Ethambutol Hydrochloride Tablets, US Prescribing Information (Warnings and Precautions).
- EyeWiki, American Academy of Ophthalmology (2026). Ethambutol Optic Neuropathy.
- Sudhakar P, Acharya K, Kini TA. Frontiers in Neurology, peer-reviewed clinical minireview (2025;16:1626909) (2025). Ethambutol optic neuropathy.
- Kim J, Ahn SJ. Toxics, peer-reviewed nationwide cohort study (PMC11359443) (2024). Risk Factors of Optic Neuropathy in Ethambutol Users: Interaction with Isoniazid and Other Associated Conditions of Toxic Optic Neuropathy.
- Saxena R, Singh D, Phuljhele S, et al. Indian Journal of Ophthalmology, expert panel consensus statement (PMC8837289) (2021). Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy.
- Nahid P, et al. Clinical Infectious Diseases, joint society clinical practice guideline (2016;63(7):853-867) (2016). Official American Thoracic Society, CDC, and Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.